Publications by authors named "David Rog"

Claim this Profile
E
Employment status in people with multiple sclerosis: Profile, dynamic changes and determinants over time.
Carolyn A Young, David Rog, Radu Tanasescu, Basil Sharrack, Seema Kalra, Roger Mills

Mult Scler Relat Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Jeremy Chataway, Thomas Williams, James Blackstone, Nevin John, Marie Braisher, David Rog

Lancet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of relative deprivation and ethnicity on the incidence rate of amyotrophic lateral sclerosis.
James Alder, Chukwu Chukwuma, Tracey Farragher, Samantha Holden Smith, Rosemary Morris, David Rog

Amyotroph Lateral Scler Frontotemporal Degener· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assisted reproduction technology in multiple sclerosis.
Ger Mullan, Stella Hughes, David Rog, Peter Brex, Ruth Dobson

Pract Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and socio-demographic characteristics of people with multiple sclerosis at the time of diagnosis: Influences on outcome trajectories.
Carolyn A Young, David Rog, Basil Sharrack, Suresh K Chhetri, Seema Kalra, Roger Mills

J Neurol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnicity and deprivation negatively impact the access to disease-modifying therapy for relapsing-remitting multiple sclerosis: a retrospective, single-centre study.
Joyutpal Das, Gagana Mallawaarachchi, Jack Grimshaw, Thomas Jackson, Paul Talbot, David Rog

J Neurol Neurosurg Psychiatry· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical and psychological aspects of multiple sclerosis: Revisiting the Multiple Sclerosis Impact Scale (MSIS-29).
Carolyn A Young, David J Rog, Basil Sharrack, Radu Tanasescu, Seema Kalra, Roger J Mills

Mult Scler· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.
James Blackstone, Thomas Williams, Jennifer M Nicholas, Ekaterina Bordea, Floriana De Angelis, David Rog

BMJ Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconciling lesions, relapses and smouldering associated worsening: A unifying model for multiple sclerosis pathogenesis.
Niraj Mistry, Jeremy Hobart, David Rog, Nils Muhlert, Joela Mathews

Mult Scler Relat Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, treatment and correlates of depression in multiple sclerosis.
Carolyn A Young, Dawn Langdon, David Rog, Suresh Kumar Chhetri, Radu Tanasescu, Roger Mills

Mult Scler Relat Disord· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates and trajectories of relapses in relapsing-remitting multiple sclerosis.
Carolyn A Young, David J Rog, Basil Sharrack, Radu Tanasescu, Seema Kalra, Roger J Mills

Neurol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of Ireland.
Ashvin Kuri, David E Henshall, Daoud Chaudhry, Setthasorn Zhi Yang Ooi, Qiqi Zhang, David Rog

BMC Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry.
Kerstin Hellwig, David Rog, Christopher McGuigan, Maria K Houtchens, Denise R Bruen

Mult Scler· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis in the United Kingdom: A time and motion study.
David Rog, Wallace Brownlee, Francisco Javier Carod-Artal, Seema Kalra, Noreen Barker

Mult Scler Relat Disord· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
University education facilitates uptake of disease-modifying therapies for multiple sclerosis: A community-based study using the UK MS Register.
Joyutpal Das, David J Rog, Rod Middleton, Jeff W Rodgers, Richard Nicholas

Mult Scler· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic disparities in the epidemiological and clinical characteristics of multiple sclerosis.
Gagana Mallawaarachchi, David J Rog, Joyutpal Das

Mult Scler Relat Disord· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Sclerosis vision questionnaire (MSVQ-7): Reliability, validity, precision and discrimination.
Carolyn A Young, David J Rog, Radu Tanasescu, Seema Kalra, Dawn Langdon, Roger J Mills

Mult Scler Relat Disord· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring disability in multiple sclerosis: the WHODAS 2.0.
Carolyn A Young, David J Rog, Basil Sharrack, Cris Constantinescu, Seema Kalra, Roger J Mills

Qual Life Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient neurology diagnostic coding: a proposed scheme for standardised implementation.
Fran Biggin, Jo Knight, Rejith Dayanandan, Anthony Marson, Martin Wilson, David Rog

Pract Neurol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK.
Benjamin M Jacobs, Luisa Schalk, Angie Dunne, Antonio Scalfari, Ashwini Nandoskar, David Rog

BMJ Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis during pregnancy and breastfeeding: A systematic review and Delphi consensus.
Priyanka Iyer, Kate Wiles, Azza Ismail, Surabhi Nanda, Katy Murray, David Rog

Mult Scler· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines.
Ruth Dobson, David Rog, Caroline Ovadia, Katy Murray, Stella Hughes

Pract Neurol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring coping in multiple sclerosis: The Coping Index-MS.
Carolyn A Young, Roger J Mills, Dawn Langdon, David J Rog, Basil Sharrack

Mult Scler· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS).
Ruth Dobson, Matthew Craner, Ed Waddingham, Aleisha Miller, Jayant Pindoria, David Rog

Mult Scler Relat Disord· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The four self-efficacy trajectories among people with multiple sclerosis: Clinical associations and implications.
Carolyn A Young, Roger Mills, Dawn Langdon, Basil Sharrack, Tahir Majeed, David Rog

J Neurol Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis